XERIS PHARMACEUTICALS INC Net Income
XERIS PHARMACEUTICALS INC reported Net Income of -$27.52 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2021-08-05
- XERIS PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2021-06-30 was -$27.52M.
- XERIS PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2021-03-31 was -$18.41M.
- XERIS PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2020-12-31 was -$21.86M.
- XERIS PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2020-09-30 was -$16.00M.
- XERIS PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2020 was -$91.14M.
- XERIS PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2019 was -$125.58M.
- XERIS PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2018 was -$60.08M.
- XERIS PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2017 was -$26.55M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$27.52M 10-Q · filed 2021-08-05 | -$45.93M 10-Q · filed 2021-08-05 | -$67.78M derived: sum of 3 quarters · filed 2021-08-05 | -$83.78M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | -$18.41M 10-Q · filed 2021-08-05 | -$40.27M derived: sum of 2 quarters · filed 2021-08-05 | -$56.27M derived: sum of 3 quarters · filed 2021-08-05 | -$80.37M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | -$21.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$37.86M derived: sum of 2 quarters · filed 2021-03-09 | -$61.96M derived: sum of 3 quarters · filed 2021-08-05 | -$91.14M 10-K · filed 2021-03-09 |
| 2020-09-30 | -$16.00M 10-Q · filed 2020-11-09 | -$40.10M derived: sum of 2 quarters · filed 2021-08-05 | -$69.28M 10-Q · filed 2020-11-09 | -$102.36M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | -$24.10M 10-Q · filed 2021-08-05 | -$53.28M 10-Q · filed 2021-08-05 | -$86.36M derived: sum of 3 quarters · filed 2021-08-05 | -$119.20M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$29.18M 10-Q · filed 2021-08-05 | -$62.27M derived: sum of 2 quarters · filed 2021-08-05 | -$95.10M derived: sum of 3 quarters · filed 2021-08-05 | -$129.49M derived: sum of 4 quarters · filed 2021-08-05 |
| 2019-12-31 | -$33.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$65.92M derived: sum of 2 quarters · filed 2021-03-09 | -$100.30M derived: sum of 3 quarters · filed 2021-03-09 | -$125.58M 10-K · filed 2021-03-09 |
| 2019-09-30 | -$32.84M 10-Q · filed 2020-11-09 | -$67.22M derived: sum of 2 quarters · filed 2020-11-09 | -$92.50M 10-Q · filed 2020-11-09 | -$112.92M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$34.38M 10-Q · filed 2020-11-09 | -$59.66M 10-Q · filed 2020-08-10 | -$80.08M derived: sum of 3 quarters · filed 2020-11-09 | -$94.85M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-03-31 | -$25.28M 10-Q · filed 2020-11-09 | -$45.70M derived: sum of 2 quarters · filed 2020-11-09 | -$60.46M derived: sum of 3 quarters · filed 2020-11-09 | -$73.45M derived: sum of 4 quarters · filed 2020-11-09 |
| 2018-12-31 | -$20.42M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$35.19M derived: sum of 2 quarters · filed 2020-03-12 | -$48.17M derived: sum of 3 quarters · filed 2020-03-12 | -$60.08M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$14.77M 10-Q · filed 2019-11-07 | -$27.75M derived: sum of 2 quarters · filed 2019-11-07 | -$39.66M 10-Q · filed 2019-11-07 | -$48.81M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$12.99M 10-Q · filed 2019-11-07 | -$24.89M 10-Q · filed 2019-08-06 | -$34.04M derived: sum of 3 quarters · filed 2019-11-07 | -$41.57M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-03-31 | -$11.91M 10-Q · filed 2019-11-07 | -$21.05M derived: sum of 2 quarters · filed 2019-11-07 | -$28.58M derived: sum of 3 quarters · filed 2019-11-07 | -$33.81M derived: sum of 4 quarters · filed 2019-11-07 |
| 2017-12-31 | -$9.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$16.67M derived: sum of 2 quarters · filed 2019-03-06 | -$21.91M derived: sum of 3 quarters · filed 2019-03-06 | -$26.55M 10-K · filed 2019-03-06 |
| 2017-09-30 | -$7.53M 10-Q · filed 2018-11-08 | -$12.76M derived: sum of 2 quarters · filed 2018-11-08 | -$17.41M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | -$5.23M 10-Q · filed 2018-08-14 | -$9.88M 10-Q · filed 2018-08-14 |